[Progress in the study on the molecules in CD28 family]

Area of Science:

• Immunology
• Molecular Biology
• Cellular Signaling

Background:

• The CD28 family comprises CD28, ICOS, CTLA-4, and PD-1 molecules, functioning as critical regulators of T cell responses.
• CD28 and ICOS act as activation receptors, while CTLA-4 and PD-1 function as inhibitory receptors.
• These receptors interact with the B7 family molecules to modulate T cell activation, homeostasis, and immune responses.

Purpose of the Study:

• To investigate the signaling mechanisms of CD28 family members, particularly CD28 and CTLA-4.
• To explore the role of these receptors in T cell activation and homeostasis.
• To evaluate the current understanding and identify knowledge gaps in the dual-signaling model.

Main Methods:

• Review of existing literature on CD28 family signaling pathways.
• Analysis of T cell activation and homeostasis studies involving CD28, ICOS, CTLA-4, and PD-1.
• Comparative analysis of signaling mechanisms between activation and inhibition receptors.

Main Results:

• CD28 and CTLA-4 signaling mechanisms are relatively well-characterized but require further elucidation.
• The interplay between CD28 family members and B7 ligands is vital for T cell subset homeostasis.
• Existing data suggests a dual-signaling model, but comprehensive validation is pending.

Conclusions:

• The CD28 family plays a pivotal role in T cell immunity through a balance of co-stimulatory and co-inhibitory signals.
• Further research is essential to fully substantiate the dual-signaling model and its implications for immune regulation.
• Understanding these mechanisms is key for developing novel immunotherapies.